Suares D - Search Results

1

The application of nanoparticles as advanced drug delivery systems in Attenuating COPD.

Jessamine V, Mehndiratta S, De Rubis G, Paudel KR, Shetty S, Suares D, Chellappan DK, Oliver BG, Hansbro PM, Dua K. Jessamine V, et al. Among authors: suares d. Heliyon. 2024 Feb 1;10(3):e25393. doi: 10.1016/j.heliyon.2024.e25393. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38356590 Free PMC article. Review.

2

Uncovering the Emerging Prospects of Lipid-based Nanoparticulate Vehicles in Lung Cancer Management: A Recent Perspective.

Gupta DS, Suares D. Gupta DS, et al. Among authors: suares d. Pharm Nanotechnol. 2024 Mar 11. doi: 10.2174/0122117385286781240228060152. Online ahead of print. Pharm Nanotechnol. 2024. PMID: 38468532

3

Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery.

Suares D, Prabhakar B. Suares D, et al. Drug Dev Ind Pharm. 2017 Feb;43(2):213-224. doi: 10.1080/03639045.2016.1232726. Epub 2016 Sep 21. Drug Dev Ind Pharm. 2017. PMID: 27593545

4

Comparison of Nanoemulsion and Aqueous Micelle Systems of Paliperidone for Intranasal Delivery.

Pidaparthi K, Suares D. Pidaparthi K, et al. Among authors: suares d. AAPS PharmSciTech. 2017 Jul;18(5):1710-1719. doi: 10.1208/s12249-016-0640-x. Epub 2016 Oct 6. AAPS PharmSciTech. 2017. PMID: 27714701

5

Tumor Microenvironment Targeted Nanotherapy.

Fernandes C, Suares D, Yergeri MC. Fernandes C, et al. Among authors: suares d. Front Pharmacol. 2018 Oct 31;9:1230. doi: 10.3389/fphar.2018.01230. eCollection 2018. Front Pharmacol. 2018. PMID: 30429787 Free PMC article.

6

Cancer cell fusion: a potential target to tackle drug-resistant and metastatic cancer cells.

Fernandes C, Prabhu P, Juvale K, Suares D, Yc M. Fernandes C, et al. Among authors: suares d. Drug Discov Today. 2019 Sep;24(9):1836-1844. doi: 10.1016/j.drudis.2019.05.024. Epub 2019 Jun 1. Drug Discov Today. 2019. PMID: 31163272 Review.

7

Taste Masked Orodispersible Formulation of Fexofenadine Hydrochloride Using Ion Exchange Resins.

Suares D, Hiray A. Suares D, et al. Indian J Pharm Sci. 2015 Sep-Oct;77(5):550-5. doi: 10.4103/0250-474x.169027. Indian J Pharm Sci. 2015. PMID: 26798169 Free PMC article.

8

FTIR assay method for UV inactive drug carisoprodol and identification of degradants by RP-HPLC and ESI-MS.

Acharya PC, Vasi R, Suares D. Acharya PC, et al. Among authors: suares d. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 1;1029-1030:16-21. doi: 10.1016/j.jchromb.2016.06.041. Epub 2016 Jun 25. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 27398631

9

In silico exploration of CB2 receptor agonist in the management of neuroinflammatory conditions by pharmacophore modeling.

Bodke S, Joshi N, Alavala RR, Suares D. Bodke S, et al. Among authors: suares d. Comput Biol Chem. 2024 Jun;110:108049. doi: 10.1016/j.compbiolchem.2024.108049. Epub 2024 Mar 10. Comput Biol Chem. 2024. PMID: 38507844

10

[Pulmonary embolism].

PATARO VF, SUARES DZ, PIOMBO HS. PATARO VF, et al. Among authors: suares dz. Prensa Med Argent. 1960 Sep 2;47:2409-17. Prensa Med Argent. 1960. PMID: 13733240 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page